Feng Huang Wang·2025-11-17 22:54Market Overview - The Dow Jones index fell by 1.18% to 46,590.24 points, the S&P 500 index dropped by 0.92% to 6,672.41 points, and the Nasdaq index decreased by 0.84% to 22,708.07 points [2] - The S&P 500 index has declined over 2% in November, following six consecutive months of gains, and is down more than 3% from its historical high, while the Nasdaq has fallen over 5% from its peak [2] - Concerns about overvaluation of tech stocks have dominated the market, particularly as Wall Street scrutinizes the fundamentals of the AI hype [2] Company News - Amazon issued $15 billion in bonds to finance AI infrastructure, with the issuance exceeding initial estimates by $3 billion, attracting $80 billion in subscription demand [5][6] - Novo Nordisk announced a price reduction for its obesity drug Wegovy to $349 per month, a 30% decrease from the previous price of $499, aligning it with Eli Lilly's Zepbound pricing [7][8] - Johnson & Johnson has agreed to acquire Halda Therapeutics for $3.05 billion in cash, with the transaction expected to close in the coming months [10] - Sohu's stock rose by 7.26% after reporting a total revenue of $180 million for Q3, a 19% increase year-over-year, and a net profit of $9 million, marking a return to profitability [11] Stock Performance - Major tech stocks mostly declined, with Nvidia down 1.83%, Apple down 1.82%, Microsoft down 0.53%, while Google rose 3.11% [4] - Chinese stocks on Nasdaq also saw a decline, with the Nasdaq Golden Dragon China Index down 1.21%, although Alibaba and JD.com saw gains of 2.54% and 0.72% respectively [4]